Wiley Bros. Aintree Capital, LLC Insmed Inc Transaction History
Wiley Bros. Aintree Capital, LLC
- $8.04 Billion
- Q4 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Insmed Inc stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 4,933 shares of INSM stock, worth $399,868. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,933
Previous 4,902
0.63%
Holding current value
$399,868
Previous $357,000
4.76%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding INSM
# of Institutions
497Shares Held
189MCall Options Held
3.21MPut Options Held
2.72M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.48 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.16 Billion0.02% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y913MShares$1.05 Billion84.75% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.7MShares$1.03 Billion0.1% of portfolio
-
Capital International Investors Los Angeles, CA7.12MShares$577 Million0.1% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $11B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...